01—Abstract
Summary
Summary of the 8-K/A filed February 26, 2024. Cited figures are marked; the original filing is the authoritative source.
This 8-K/A filing from HCA Healthcare, Inc. serves as an amendment to a previous 8-K announcing the appointment of Michael A.
Marks as Executive Vice President and Chief Financial Officer, effective May 1, 2024. The primary purpose of this amendment is to disclose material changes to Mr. Marks' compensation arrangements related to his new role, which were not finalized at the time of the initial filing. Key details of the compensation changes include the establishment of the 2024 Executive Officer Performance Excellence Program (Executive Officer PEP).
Under this program, Mr. Marks' performance awards will be weighted 80%a towards EBITDA targets and 20% towards specific quality metrics. These quality metrics encompass Healthcare-Associated Infections and Sepsis, Complication and Mortality, and Care Experience. His award opportunity will increase from 65% of base salary to 110% of base salary upon assuming the CFO role.
02—Key points
Key Highlights
- Amendment to a prior 8-K filing regarding the appointment of Michael A. Marks as EVP & CFO.
- Disclosure of material compensation changes for the new CFO, Michael A. Marks.
- Introduction of the 2024 Executive Officer Performance Excellence Program (Executive Officer PEP).
- CFO compensation linked to performance with 80% weighted towards EBITDA and 20% towards quality metrics.
- Quality metrics include Healthcare-Associated Infections, Complication/Mortality, and Care Experience.
- CFO's performance award opportunity increases from 65% to 110% of base salary upon assuming the CFO role on May 1, 2024.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K/A filing?
This filing amends a previous 8-K to provide details on the compensation package for the newly appointed Executive Vice President and Chief Financial Officer, Michael A. Marks, which were not finalized at the time of the initial announcement.
How will the new CFO's compensation be determined?
The new CFO's compensation is tied to performance through the 2024 Executive Officer PEP. Awards are weighted 80% on EBITDA targets and 20% on specific quality metrics, demonstrating a focus on both financial performance and operational quality.
What are the key components of the quality metrics for the CFO's performance award?
The quality metrics are divided into three categories: Healthcare-Associated Infections and Sepsis (30%), Complication and Mortality (30%), and Care Experience (40%).
When does the CFO's compensation increase take effect?
The CFO's performance award opportunity increases from 65% to 110% of his base salary effective May 1, 2024, which is the date he officially assumes the role of Executive Vice President and Chief Financial Officer.
04—Continue